Pfizer Says Omicron-Specific Vaccine Ready by March

Tuesday, January 11, 2022 (HealthDay Information)

Pfizer Inc. stated Tuesday {that a} COVID-19 vaccine that particularly targets the Omicron variant will probably be prepared by March.

The corporate has begun creating a brand new model of the vaccine, stated Pfizer CEO Albert Baurla. CNBCOf “squawk field,” CBS Information Reported.

U.S. Omicron now accounts for greater than 98% of all new COVID-19 circumstances in the US, in line with the Facilities for Illness Management and Prevention.

An organization spokesman stated in a press release that Pfizer was additionally working to enhance its present Covid-19 vaccine, “to deal with any future sort of potential concern, if mandatory.” CBS Cash Watch.

“If a 3rd dose with the present vaccine isn’t obtainable to guard in opposition to the Omicron variant or different future variants, Pfizer expects to have the ability to develop and produce a tailored vaccine in opposition to that variant in roughly 100 days, topic to regulatory approval.” The spokesman added.

Additionally on Monday, Moderna stated in a press release that it was additionally creating an Omicron-specific vaccine, CBS Information Reported.

“Given the long-term dangers posed by Omicron’s immunity, Moderna will proceed to develop an Omicron-specific variant of the vaccine that it expects to advance in scientific trials in early 2022,” the corporate stated.

Within the meantime, the booster shot stays the perfect protection in opposition to Omicron, consultants stated.

In December, the White Home’s chief medical adviser, Dr. Anthony Fawcett predicted that Omicron would grow to be the dominant virus pressure in the US however he didn’t say {that a} new Omicron-specific shot was wanted to keep up immunity. As an alternative, it has urged Individuals to get booster photographs, which research have begun to offer the perfect safety in opposition to omikrons.

A current research by the UK Well being Safety Company discovered that booster photographs are as much as 75% efficient in stopping COVID-19 infections attributable to Omicron.

Extra data

Go to the US Meals and Drug Administration for extra data on COVID vaccines.

Sources: Moderna Inc., Information Launch, January 10, 2022; CBS Information

Robin Foster

Medical News
Copyright © 2021 HealthDay. All rights reserved.


More News click here